Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com

Firm News

Valeant Pharmaceuticals Completes Bond Offering

Date: 02/08/11

Cahill represented the initial purchasers in a Rule 144A/Reg S Offering of $650 million of 6.750% Senior Notes due 2021 by Valeant Pharmaceuticals International. Valeant intends to use the net proceeds from the offering of the Notes to finance acquisitions and for general corporate purposes.

Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com